// App-Quantinova.ai

THU0039 : DECIPHERING DISEASE-RELEVANT T CELL SUBSETS IN RHEUMATOID ARTHRITIS IDENTIFIES A NOVEL CELLULAR SUBSET OF PATHOGENETIC IMPORTANCE IN THERAPEUTIC RESISTANCE.

Researchers

Presenter

  • M. Nyirenda

Principal Investigators

  • I. Mcinnes

  • C. Goodyear

Medical Centers

  • Institute of Infection, Immunity and Inflammation, College of Medicine, Veterinary Medicine and Life Sciences, University of Glasgow, Glasgow, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • Peripheral blood mononuclear cell

  • C-C Motif Chemokine Receptor 2

  • C-C Motif Chemokine Receptor 5

  • Cluster of Differentiation 4

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Bristol-Myer Squibb

Result

  • N/A